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symptoms in a Canadian palliative home care
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Abstract
Background: Depression in palliative care patients is important because of its intrinsic burden and association with
elevated physical symptoms, reduced immunity and increased mortality risk. Identifying risk factors associated with
depression can enable clinicians to more readily diagnose it, which is important since depression is treatable. The
purpose of this cross-sectional study was to determine the prevalence of depressive symptoms and risk factors
associated with them in a large sample of palliative home care patients.
Methods: The data come from interRAI Palliative Care assessments completed between 2006 and 2012. The sample
(n = 5144) consists of adults residing in Ontario (Canada), receiving home care services, classified as palliative, and
not experiencing significant cognitive impairment. Logistic regression identified the risk factors associated with
depressive symptoms. The dependent variable was the Depression Rating Scale (DRS) and the independent
variables were functional indicators from the interRAI assessment and other variables identified in the literature. We
examined the results of the complete case and multiple imputation analyses, and found them to be similar.
Results: The prevalence of depressive symptoms was 9.8%. The risk factors associated with depressive symptoms
were (pooled estimates, multiple imputation): low life satisfaction (OR = 3.01 [CI = 2.37-3.82]), severe and moderate
sleep disorders (2.56 [2.05-3.19] and 1.56 [1.18-2.06]), health instability (2.12 [1.42-3.18]), caregiver distress 2.01
[1.62-2.51]), daily pain (1.73 [1.35-2.22]), cognitive impairment (1.45 [1.13-1.87]), being female (1.37 [1.11-1.68]),
and gastrointestinal symptoms (1.27 [1.03-1.55]). Life satisfaction mediated the effect of prognostic awareness on
depressive symptoms.
Conclusions: The prevalence of depressive symptoms in our study was close to the median of 10-20% reported in
the palliative care literature, suggesting they are present but by no means inevitable in palliative patients. Most of
the factors associated with depressive symptoms in our study are amenable to clinical intervention and often
targeted in palliative care programs. Designing interventions to address them can be challenging, however,
requiring careful attention to patient preferences, the spectrum of comorbid conditions they face, and their social
supports. Life satisfaction was one of the strongest factors associated with depressive symptoms in our study, and is
likely to be among the most challenging to address.
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Background
Depression is one of the most common mental health
problems worldwide [1]. It is also considered to be
common [2], but by no means inevitable [3], in palliative
care populations. Estimated prevalence rates for depression
in palliative care populations vary widely, from 1 to 77%
with a median of 10-20% [4-6]. Systematic reviews attribute
the wide range of prevalence rates to a number of factors,
including small samples, variation in assessment tools
used, and classification of symptoms [6,7]. Common
methodological criticisms include reliance on screening
instruments that have not been validated in a palliative
population, the lack of a clear definition of depression, and
inclusion of somatic symptoms (e.g., weight loss) in depres-
sion scales thereby introducing symptom overlap with the
effects and/or treatment of the terminal illness [5-8].
While the probable consequence of many of these weak-
nesses is to inflate prevalence rates [6,7], this is offset by the
known barriers to detection and management of depression.
The diagnosis of depression is not straightforward in older
patients generally [9], who represent a significant proportion
of the palliative care population. Diagnostic challenges
unique to the palliative care setting also arise, such as
distinguishing depression from the normal grief process
or neurovegetative symptoms (e.g., sleep, appetite,
concentration) that often accompany cancer and/or
its treatment. Physicians may be reluctant to diagnose
depression because they view treatment as adding to
an already high medication burden or having limited
effectiveness [4,10]. Oncologists and palliative care
clinicians also cite a lack of time to perform the necessary
diagnostic work as a significant barrier to diagnosing
depression [4]. Yet, untreated depression reduces the
quality of life of palliative patients, and has been
associated with increased physical symptoms such as
pain and fatigue, resulting in more hospitalizations and
physician visits [11,12]. Depression is an independent risk
factor for cancer mortality [13], is associated with an
increased desire for death and assisted suicide [14], can
reduce compliance with treatment [15,16], can decrease
immune system response, and can cause patients to avoid
making important health care decisions or plans for
personal affairs [10]. This suggests that depression can be
a very serious disorder, yet it appears to be treatable even
in palliative populations [10,17-19].
Previous studies that have examined depression in
palliative care patients have established associations
with certain physical symptoms (e.g., sleep disorders,
fatigue, dyspnea, pain, functional disability) [2,4,20,21],
psychological symptoms (psychological well-being,
spirituality, hopelessness, cognitive loss) [20,22,23], demo-
graphic variables (e.g., younger age, gender) [2,21,24,25],
prognosis [2], prognostic awareness [26,27], social support
[5,21,28,29], and caregiver distress [30,31]. However, prior
research has been limited in several ways, notably the lack
of sufficient sample sizes [5], samples that do not include
people being treated in home settings [32], and the
use of assessment tools that have not been validated
in a palliative population [3,5].
To address these limitations, we conducted a study
using a validated tool to screen for depression in a large
sample of palliative home care patients. Specifically, we
examined the prevalence and risk factors associated with
depressive symptoms in a cross-sectional analysis of an
existing dataset consisting of home care patients in
Ontario (Canada) that were classified as palliative (or
end-of-life). The aim was to assist clinicians in identifying
palliative care patients at risk of depression that would most
likely benefit from further assessment and intervention to
address depression.
Methods
Study sample
The interRAI Palliative Care (interRAI PC) assessments
were completed between 2006 and 2012 by trained case
managers using all sources of information available at the
time of assessment. Assessors compared the information
to standardized coding rules and item definitions, and
followed a standard protocol outlined in the interRAI PC
manual [33]. The interRAI PC is a copyrighted instrument
(www.interrai.org) designed for adults (18+) with palliative
and end-of-life needs, regardless of setting (e.g., acute care,
hospice, home care). The assessments were part of a pilot
implementation of the interRAI PC in six of fourteen
home care provider organizations in Ontario. All
clients in the six sites who were classified as palliative
were assessed with the interRAI PC. Patients were
classified as palliative by the home care case manager
if they were no longer responsive to curative treatment,
considered to be dying, and the goal of care was to alleviate
distressing symptoms in the last stage of their illness
[34]. Informed consent was obtained from clients for
participation in the pilot.
The study sample consisted of patients in the pilot who
were 18+ living in Ontario, and not experiencing significant
cognitive impairment (i.e., Cognitive Performance Score
[CPS] < 4, see “Measures” below). Eliminating patients
with significant cognitive impairment was done because
neurodegeneration can interfere with patients’ emotional
disposition, making it challenging for clinicians to diagnose
depression [35].
Measures
All variables used in the analyses were derived from infor-
mation in the interRAI PC, which is one of a number of
interRAI instruments currently used as routine assessments
in countries within North America, the Nordic region,
Western Europe, the Czech Republic and Japan. InterRAI
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instruments feature a number of consistently-defined mea-
sures and scales. This facilitates their portability
across service sectors and can foster continuous improve-
ment, especially in palliative care services, which are
increasingly being delivered by a range of multidisciplinary
service providers.
InterRAI PC depression rating scale (DRS)
The dependent variable in this study was the score on the
interRAI Depression Rating Scale (DRS). The DRS is an
assessor-rated score created by summing the responses to
the following 7 items: made negative statements, persistent
anger with self or others, expressions of seemingly
unrealistic fears, repetitive health complaints, repetitive
non-health complaints, sad/pained/worried facial expres-
sions, and crying and tearfulness. The four item response
categories are rescaled and the responses summed to
generate a DRS score ranging from 0 to 14. A score
of three or higher has been shown to be predictive of
a clinically-confirmed depression diagnosis [36]. The
DRS has been validated against the Hamilton Depression
Rating Scale, the Cornell Scale for Depression in Dementia,
and psychiatrists’ ratings [36]. Unidimensionality, reliability
and validity of the DRS in a palliative care population were
also recently demonstrated, with the evidence including: a
Mökken Scale homogeneity coefficient of 0.34, ordinal
reliability measures ranging from 0.78 to 0.86, higher
correlations of the DRS with mood items compared to
physical function items (indicating convergent and diver-
gent validity), and the ability of the DRS to distinguish
between subgroups of patients in the expected manner [37].
Other interRAI PC scales
The interRAI PC contains a number of embedded health
index scales. For example, the Cognitive Performance
Scale (CPS) can range from 0 (cognitively intact) to 6
(very severe impairment), and it has been validated against
the Mini-Mental State Examination [38]. Functional
performance was measured using the Activities of
Daily Living Self-performance Hierarchy Scale (ADL
SHS), which categorizes 4 ADLs (locomotion, eating,
personal hygiene, toilet use) on a scale ranging from
0 (independence) to 6 (total-dependence in late-loss ADLs)
[39]. A score of 2 or more represents a conventionally-used
cut-off indicating that limited assistance is required for at
least one of the ADLs. Pain was assessed using a four-point
pain scale ranging from 0 (no pain) to 3 (excruciating
daily pain), with a cut-off of 2 used to identify patients
experiencing daily pain. The pain scale has been validated
against the Visual Analogue Scale [40] and is used as
an outcome quality indicator in home care settings [9].
Health instability and illness severity was measured using
the Changes in Health, End-Stage disease and Signs and
Symptoms (CHESS) scale. Scores range from 0 to 5, with
5 representing the highest level of health instability. The
CHESS score is a very strong predictor of mortality
independent of age and a number of other factors
[41], and successfully predicts adverse outcomes compared
to other measures [42].
InterRAI PC items
Other independent variables were identified from a
review of the palliative care literature, and included in
the model subject to availability within the interRAI PC
and significance in terms of their association with the DRS.
An alpha level of 0.25 was used for the χ2 significance tests
to identify the initial list of independent variables to guard
against the omission of potentially-important variables.
Additional file 1: Table S1 provides the definitions for the
independent variables. Some variables were composite
measures that were either summative (sleep disorders,
gastrointestinal disorders) or conditional on the presence of
one or more situations (caregiver distress, life satisfaction).
For life satisfaction, principal component factor analysis
and the Cronbach’s alpha coefficient were used to confirm
the validity of combining five (conceptually broad) items
into one measure. Factor analysis confirmed a 1-factor
solution, all factor loadings were high (0.67-0.81), and the
Cronbach’s alpha was 0.77 suggesting acceptable internal
consistency.
Statistical analysis
A multivariate logistic regression model was created
using the DRS as the dichotomous dependent variable
(DRS ≥ 3 versus <3) and the interRAI functional indicators
and other significant items (p ≤ 0.25) as independent vari-
ables. The independent variables considered for inclusion
in the regression model are listed in the first column of
Table 1. All variables were categorical with the categories
determined by examining logit plots and univariate statis-
tics measuring distributional properties. The derivation and
meaning of response categories for the independent
variables is provided in the (Additional file 1: Table S1,
second and third columns).
Multicollinearity was assessed using polychoric correla-
tions because these are preferred as a measure of associ-
ation for ordinal data [43,44]. A cutoff of 0.40 was used to
identify variable pairs where elimination of one item was re-
quired to avoid mulit-collinearity problems. The following
variable pairs exceeded the cutoff:
 prognosis with the CHESS score;
 prognosis and the CHESS score with the ADL SHS
score and appetite problems;
 the CHESS score with dyspnea;
 the CPS score with communication problems and
the ADL SHS score; and
 marital status with living alone.
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Table 1 Item subgroups stratified by DRSc cutoff
Item Categories Unadjusted
OR (95% CI)a
All patients (%)
nb N = 5144
DRS < 3% (n)
N = 4339
DRS ≥ 3% (n)
N = 448h
p value for χ2 test
of Significance
% (n)
missingi
Age 18-64 1.8 (1.3, 2.5) 34.0% (1626) 33.0% (1432) 43.3% (194) <0.0001 0.0% (0)
65-74 1.3 (0.9, 1.9) 25.5% (1219) 25.5% (1107) 25.0% (112)
75-84 1.1 (0.7,1.5) 28.7% (1375) 29.3% (1273) 22.8% (102)
85+ Reference 11.8% (567) 12.2% (527) 8.9% (40)
Gender Female 1.2 (1.0,1.5) 50.9% (2422) 50.4% (2175) 55.6% (247) 0.0369 0.6% (30)
Male Reference 49.1% (2335) 49.6% (2138) 44.4% (197)
Marital status No partner 1.0 (0.8. 1.2) 38.7% (1785) 38.8% (1622) 38.3% (163) 0.8359 3.7% (178)
Married or have partner Reference 61.3% (2824) 61.2% (2561) 61.7% (263)
Sitec windsor Site 1 0.6 (0.3,1.1) 3.6% (174) 3.7% (161) 2.9% (13) 0.1079 0.0% (0)
Site 2 0.7 (0.4, 1.0) 64.4% (3083) 64.8% (2812) 60.5% (271)
Site 3 0.7 (0.5, 1.2) 16.8% (802) 16.7% (726) 17.0% (76)
Site 4 0.9 (0.5, 1.5) 8.3% (397) 8.1% (352) 10.0% (45)
Site 5 1.1 (0.6, 2.2) 2.4% (116) 2.3% (100) 3.6% (116)
Site 6 Reference 4.5% (215) 4.3% (188) 6.0% (27)
Co-morbidities (#)d C 5+ 1.8 (1.3, 2.4) 9.6% (458) 9.1% (395) 14.1% (63) 0.0003 0.0% (0)
3-4 1.3 (1.0,1.6) 32.7% (1564) 32.4% (1405) 35.5% (159)
0-2 Reference 57.8% (2765) 58.5% (2539) 50.5% (226)
Diagnosis prima Cancer 0.8 (0.5, 1.1) 86.5% (4141) 91.6% (3791) 8.4% (350) 0.3094 0.0% (0)
Cardiovascular 0.7 (0.4, 1.1) 4.6% (220) 92.6% (204) 7.4% (16)
COPD 0.7 (0.3, 1.5) 1.7% (81) 92.6% (75) 7.4% (6)
Other Reference 7.2% (345) 89.1% (307) 10.9% (38)
Prognosis Death imminent (days)
- < 6 wks
2.7 (2.0,3.8) 8.6% (358) 7.9% (295) 14.9% (74) <0.0001 12.8%
(615)
>6 wks - < 6 mths 1.6 (1.3, 2.1) 47.6% (1987) 47.0% (1760) 53.7% (227)
6+ mths Reference 42.8% (1827) 45.2% (1694) 31.4% (133)
CHESSe Moderate, Severe (2+) 3.3 (2.2, 4.8) 83.0% (3770) 81.9% (3359) 93.6% (412) <0.0001 5.1% (247)
None, Minimal (0,1) Reference 17.0% (770) 18.1% (742) 6.4% (28)
Awareness of
prognosis
No 1.4 (1.1, 1.8) 45.8% (924) 44.2% (786) 52.5% (138) 0.0122 13.0%j
(305)
Yes Reference 54.7% (1116) 55.8% (991) 47.5% (125)
Pain scale Moderate-Severe ((2+) 2.4 (1.9, 3.0) 64.1% (3034) 62.6% (2680) 79.7% (354) <0.0001 1.2% (59)
None, Minimal (0,1) Reference 35.8% (1694) 37.4% (1604) 20.3% (90)
CPSf Moderate-high
impairment (2+)
2.1 (1.7, 2.6) 16.6% (796) 15.5% (671) 27.9% (125) <0.0001 0.0% (0)
None, Low impairment
(0,1)
Reference 83.4% (3991) 84.5% (3668) 72.1% (323)
ADL SHSg Limited, Extensive (2+) 1.4 (1.1, 1.7) 37.4% (1752) 36.7% (1560) 44.0% (192) 0.0027 2.2% (103)
Independent (0,1) Reference 62.6% (2932) 63.3% (2688) 56.0% (244)
Communication
disorders
Yes 1.2 (1.1, 1.6) 29.0% (1374) 28.5% (1223) 33.9% (151) 0.0171 1.0% (46)
No Reference 71.0% (3367) 71.5% (3072) 66.1% (295)
Sleep disorders Severe 3.5 (2.8, 4.4) 27.0% (1245) 24.9% (1039) 48.1% (206) <0.0001 3.7% (178)
Moderate 2.1 (1.6, 2.8) 17.5% (808) 17.3% (723) 19.9% (85)
Minimal Reference 55.5% (2556) 57.9% (2419) 32.0% (137)
Appetite Poor 1.7 (1.3, 2.1) 22.5% (1038) 21.5% (898) 31.8% (140) <0.0001 3.5% (166)
Good Reference 77.5% (3583) 78.5% (3283) 68.2% (300)
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Prognosis and the CHESS score are both mortality
measures. CHESS was retained in the model instead of
prognosis because it has been validated and displays less
assessor variability in use and judgement [41]. Dyspnea,
appetite problems and the ADL SHS score were eliminated
because each of these directly relates to items used in
calculating the CHESS score [41]. The CPS score was
retained in the model instead of communication problems
because the validity and reliability of the former is well
established [38], and many studies report an association
between cognitive impairment and depression [9,45,46].
Living alone was retained in the model instead of marital
status because of the strong bi-variate association it shows
with the DRS (Table 1), and because it better captures the
extent of social isolation, which has been long recognized
as a risk factor for depression [47,48].
The impact of missing data was also considered. Although
the extent of missing data for most items is below 5%
(Table 1), restricting the analysis to clients having a response
for all variables included in the model (a complete
case analysis) reduces the sample from 5,144 to 3,734,
a reduction of 27%. While a complete case approach is
often used in health research [49], other methods are
receiving increased attention with the choice of method
depending on the pattern of missing data and the
mechanisms causing it [50]. We believe that our missing
data reflect a random process rather than systematic bias.
However, we cannot be certain which of the three
randomness patterns described in the literature applies to
our data: missing completely at random (MCAR), missing
at random (MAR), or missing not at random (MNAR)
[50]. There is no universal method of handling MNAR,
but the pattern is rare [51]. MCAR has been found to be
insensitive to the method of handling missing data [50],
but this pattern is also rare [51,52]. MAR characterizes
most missing data [51,52], and multiple imputation is
recommended for this pattern because it leads to unbiased
results with correct standard errors [50,52]. We performed
multiple imputation, and provide these results alongside
those for the complete case analysis, as has been previously
recommended [53]. Logistic regressions were performed
using backward selection and a significance level of 0.05
for retaining model variables. Risk factors were considered
significant if they were selected in at least 50% of the
logistic regressions (i.e., 50 regressions were run, one
for each of the 50 imputations conducted, with factors con-
sidered significant if they were retained in at least 25 runs).
Multiple imputation used continuous-based imputation
with rounding [54] and the results for 50 imputations
were pooled using normalizing transformations [55].
Table 1 Item subgroups stratified by DRSc cutoff (Continued)
Dyspnea Severe 1.4 (1.1, 1.8) 15.8% (750) 15.4% (662) 19.8% (88) 0.0301 1.1% (51)
Moderate 1.2 (0.9, 1.4) 29.2% (1383) 29.1% (1250) 30.0% (133)
Minimal Reference 55.0% (2603) 55.5% (2380) 50.2% (223)
Gastrointestinal
symptoms
Moderate-severe 1.9 (1.5, 2.3) 45.2%% (2037) 43.7% (1785) 59.0% (252) <0.0001 5.8% (277)
Minimal Reference 54.8% (2473) 56.3% (2298) 41.0% (175)
Life satisfaction Low life-satisfaction 2.8 (2.3, 3.5) 41.0% (1846) 38.6% (1574) 64.0% (272) <0.0001 6.0% (287)
High life-satisfaction Reference 59.0% (2654) 61.4% (2501) 36.0% (153)
Living alone Living alone 1.3 (1.0, 1.7Q) 19.3% (892) 19.6% (822) 16.0% (70) 0.0670 3.3% (157)
Living with others Reference 80.7% (3738) 80.4% (3370) 84.0% (368)
Supportive family No strong family support 1.6 (1.1, 2.4) 4.7% (222) 4.5% (191) 7.0% (31) 0.0170 1.1% (53)
Strong, supportive family Reference 95.3% (4512) 95.6% (4098) 93.0% (414)
Caregiver distress Caregiver exhibits signs
of distress
2.7 (2.2, 3.3) 23.3% (1063) 21.3% (878) 42.2% (185) <0.0001 4.7% (227)
Caregiver does not exhibit
signs of distress
Reference 76.7% (3497) 78.7% (3244) 57.8% (253)
a95% CI straddling 1.0 are not statistically significant.
bSubgroup totals are the total sample (n = 5144) less clients where DRS or item was missing.
cAll 6 sites are located in Ontario, Canada; site names not shown to protect patient confidentiality.
dIncludes primary diagnosis.
eCHESS = Change in Health, End-Stage and Disease Symptoms and Signs.
fCPS = Cognitive Performance Scale.
gADL SHS = Activities of Daily Living Self-performance Hierarchy Scale.
hCorresponds to a prevalence of depressive symptoms of 9.4% [448/(4339 + 448)×100].
iExpressed as the number missing for this item divided by the number of clients with a non-missing DRS score (4787 of the 5144 clients in the total sample),
multiplied by 100.
jExpressed as the number of clients missing for this item divided by the number of clients with non-missing DRS scores and a prognosis < 6 months (n = 2345),
multiplied by 100.
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Imputation included the outcome variable (DRS) [56]
and all independent variables left after addressing the
multi-collinearity concerns discussed above.
A special sub-analysis was undertaken to explore
whether prognostic awareness was a potential risk factor
for depression. This analysis employed a smaller sample
consisting of patients with an estimated prognosis of less
than six months, because prognostic awareness in the
interRAI PC pertains only to this subgroup. We also
tested whether the effect of prognostic awareness on
the DRS was mediated by life satisfaction, using the
methodology recommended by Frazier et al. [57]. Mediation
was examined because of the complex way that prognostic
awareness appears to interact with acceptance in shaping
depression [27]. In particular, we were interested in whether
life satisfaction (which includes acceptance and optimism)
mediated the relationship between prognostic awareness
and the DRS, in light of the research linking “peaceful
awareness” with more positive end-of-life outcomes [3,27].
It is recommended that the goodness-of-fit of prognostic
models be assessed using measures of both discrimination
and calibration [58,59]. The c statistic, which corresponds
to the area under the receiver operating characteristic
(ROC) curve, was chosen as the measure of discrimination,
and the Hosmer and Lemeshow statistic was chosen
to assess calibration. A c statistic of 0.70 or greater
indicates good sensitivity and specificity, and a Hosmer
and Lemeshow statistic that is small with a large p value
indicates acceptable model fit.
SAS Version 9.2 was used for all of the statistical analyses
(www.sas.com). The study was approved by the Office
of Research Ethics at the University of Waterloo. This
institution is responsible for managing and controlling
access to the data used in this study.
Results
Sample characteristics
Sample characteristics are provided in Table 1. Two-thirds
of the sample was over the age of 65, with an average age
of 70.0 years and a range of 19.6-107.2 years. The study
sample was evenly distributed by gender (49.1% male),
and over half (61%) were currently married. The
prevalence of symptoms of depression was 9.4% in
the full sample (patients with DRS ≥3, footnote h of
Table 1). Eighty-three percent of the sample had a
CHESS score of 2 or more, with this high percentage
reflecting the severity of illness characterizing this
palliative population. Sixteen percent of the sample had a
CPS score of 2 or more, which is approximately equal to a
score of 19.2 on the Mini-mental State Examination [38].
The assessor-reported item on prognostic awareness,
which applies to patients with an estimated prognosis of
less than six months, indicated that just over half of these
patients were aware of their prognosis. Thirty-seven
percent of the sample experienced at least a moderate
level of functional impairment, almost two-thirds had
daily pain, and 42% had at least 3 co-morbidities, with
cancer being the main diagnosis (86.5%). One quarter of
the patients reported that their caregivers were distressed,
although the vast majority (95%) reported having a
supportive family.
Independent variables for logistic regression
Table 1 provides the bivariate associations between the
independent variables and the DRS (ORs and 95% CI, χ2
p values). The DRS was significantly (p ≤ 0.05) associated
with the majority of items. The proportion of patients
with DRS scores ≥ 3 was higher for patients who: were
younger, female, had with more co-morbidity, pain,
cognitive impairment, health instability (CHESS), needed
more assistance with ADLs, sleep disorders, appetite prob-
lems, gastrointestinal problems, communication problems,
dyspnea, and caregiver distress. On the other hand, the
proportion of patients with DRS scores ≥3 was lower for
patients with an estimated prognosis of more than
6 months, high life satisfaction and more family support.
Among those with an estimated prognosis of less than six
months, prognostic awareness was associated with lower
DRS scores. There is little evidence of the DRS varying by
marital status, site, or living arrangement (alone versus
with others). There were also no significant differences in
the DRS across diagnostic categories, consistent with
a recent study by Steinhauser et al. [60].
Risk factors associated with depressive symptoms
Table 2 provides the logistic regression results for the
complete case and multiple imputation models. The
results from the two methods were similar for the risk
factors selected into the models and the relative strength
of their association with the DRS. Both methods found
that life satisfaction had the strongest association with
the DRS, and both selected the following six risk factors:
life satisfaction, CHESS, sleep disorders, pain, caregiver
distress and gender. The multiple imputation analysis
identified two additional risk factors associated with the
DRS - cognitive impairment and gastrointestinal symptoms.
The c statistic was above 0.70 for the complete case and all
multiple imputation models, indicating good sensitivity and
specificity. The Hosmer and Lemeshow statistic for the
complete case model was relatively small with a large
p value (6.97; p = 0.54), indicating model acceptability.
For the multiple imputation models, this statistic
showed much more variation compared to the c statistic,
as expected [59], but in all cases the statistic indicated
acceptable model fit.
We note that prognosis is closely related to CHESS
and performs a similar function in the model – i.e., if
prognosis is included instead of CHESS, it is a significant
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risk factor along with the seven other variables selected
into the CHESS model (see Table 2). The prognosis
model also identifies one additional risk factor, number
of co-morbidities, although the OR is significant for the
highest category only (5+). These results reflect the
conceptual overlap between CHESS and prognosis
and the strong relationship both show with the DRS
(see Figures 1 and 2).
We also examined whether prognostic awareness was
a risk factor associated with depressive symptoms. We
used multiple imputation, and ran the logistic regression
for patients with an estimated prognosis of less than six
Table 2 Risk factors associated with depressive symptoms (DRS 3+) comparison of complete case and multiple
imputation analyses (Model with CHESSb as Mortality Measure)
Independent variable Complete case analysis (n = 3734)
Adjusted odds ratio (95% confidence limit)
Multiple imputation (n = 5144)
Pooled odds ratios (Pooled 95% confidence limit)
Life satisfactiona
Low 3.070 (2.37-3.98) 3.01 (2.37-3.82)
High Reference Reference
CHESSb
2+ 2.88 (1.79-4.62) 2.122 (1.42-3.18)
0-1 Reference Reference
Sleep disordersc
Severe 2.78 (2.14-3.60) 2.56 (2.05-3.19)
Moderate 1.52 (1.10-2.11) 1.56 (1.18-2.06)
Minimal Reference Reference
Pain scale
2+ 2.18 (1.64-2.89) 1.73 (1.35-2.22)
0-1 Reference Reference
Signs of caregiver distress
Yes 1.93 (1.51-2.45) 2.01 (1.62-2.51)
No Reference Reference
Gender
Female 1.42 (1.13-1.79) 1.37 (1.11-1.68)
Male Reference Reference
Cognitive impairment
CPSd 2+ N/Se 1.45 (1.13-1.87)
0-1 Reference
Gastrointestinal symptoms
Moderate-severe N/Se 1.27 (1.03-1.55)
Minimal Reference
Goodness of fit
C statistic 0.77 0.77 (0.75-0.77)f
Hosmer & Lemeshow -χ2 6.97 5.27(1.5-14.1)f
-p 0.54 0.73 (0.08-0.99)f
-df 8 8 (8-8)f
a“High” life satisfaction indicates that the patient has all 5 of the following conditions present: a sense of completion, a sense of progress towards completion,
acceptance of the situation, inner strengths that can be encouraged/nurtured AND a positive outlook. “Low” life satisfaction” indicates that one or more of the
5 conditions are absent in the patient.
bCHESS = Changes in Health and End-Stage Disease Signs and Symptoms.
c“Sleep disorders” is a composite (summative) measure based on two items: too little sleep (5 severity levels ranging from 0 to 4) and too much sleep
(5 severity levels ranging from 0 to 4). “Severe” sleep disorders represent scores of 4+, “moderate” are scores of 2 or 3, and “minimal” are scores of 0 or 1.
dCPS = Cognitive Performance Scale.
eN/S = Not significant at alpha = 0.05 level.
fMean (Minimum-Maximum).
Fisher et al. BMC Palliative Care 2014, 13:10 Page 7 of 13
http://www.biomedcentral.com/1472-684X/13/10
months (n = 2547). Table 3 (last column) provides the
regression results for the model including CHESS and
prognostic awareness, and shows that the results were
similar to the model including CHESS only (first
column). An important finding was that prognostic
awareness was not a risk factor associated with depressive
symptoms. We also found that life satisfaction met
Frazier et al.’s [57] four mediation conditions, specifically:
significant relationships existed between prognostic
awareness and both the DRS (pooled p = 0.03) and life
satisfaction (pooled p < 0.0001), a significant relationship
existed between life satisfaction and the DRS (pooled
p < 0.0001), and the relationship between prognostic
awareness and the DRS was significantly reduced once life
satisfaction entered the model (pooled z statistic for
mediation effect = 6.82, which exceeds 1.96, the p = 0.05
significance level). Therefore, prognostic awareness may
not be a significant risk factor because life satisfaction
mediates its effect on depressive symptoms. However,
prognostic awareness may have an important indirect
effect on depressive symptoms, given the nature and
significance of its relationship with life satisfaction. For
example, our data indicate that life satisfaction was
significantly stronger among those that were aware of
their prognosis (χ2 = 98.11, p < 0.0001).
Discussion
The prevalence of depressive symptoms was 9.8% in the
complete case and multiple imputation samples (9.4% in
full sample). This may underestimate the true rate, given
that depression is often under-diagnosed in palliative
populations [1], and the exclusion of somatic symptoms
from the DRS may miss patients with genuine physical
symptoms of depression. However, our results show that
Figure 1 Average Depression Rating Scale (DRS) scores by estimated prognosis. (Males versus Females), Legend: Female ,
Male .
Figure 2 Average Depression Rating Scale (DRS) scores by CHESSa Scale Score. (Males versus Females), Legend: Female ,
Male . aChanges in Health and End-Stage Disease Signs and Symptoms.
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Table 3 Risk factors associated with depressive symptoms (DRS 3+) comparison of multiple imputation analyses models
Independent variable Model with CHESSb (n = 5144)
Pooled odds ratio (Pooled
95% confidence limit)
Model with Prognosis (n = 5144)
Pooled odds ratios (Pooled
95% confidence limit)
Model with CHESSb and prognostic
awareness (n = 2547) Pooled odds
ratios (Pooled 95% confidence limit)
Life satisfactiona
Low 3.01 (2.37-3.82) 2.58 (1.95-3.42) 3.62 (2.70-4.85)
High Reference Reference Reference
CHESSb or Prognosis
- Imminent (days) - 1.97 (1.32-2.94) -
2+ - < 6 weeks 2.122 (1.42-3.18) 1.47 (1.13-1.91) 1.71 (1.05-2.80)g
0-1 -6 + weeks, < 6mths Reference Reference Reference
Sleep disordersc
Severe 2.56 (2.05-3.19) 2.67 (2.03-3.52) 2.56 (1.93-3.39)
Moderate 1.56 (2.06-1.18) 1.82 (1.31-2.53) 1.35 (0.94-1.96)
Minimal Reference Reference Reference
Pain scale
2+ 1.73 (1.35-2.22) 1.69 (1.25-2.28) 2.09 (1.52-2.87)
0-1 Reference Reference Reference
Signs of caregiver distress
Yes 2.01 (1.62-2.51) 1.71 (1.29-2.26) 1.41 (1.08-1.85)
No Reference Reference Reference
Gender
Female 1.37 (1.11-1.68) 1.47 (1.14-1.90) 1.41 (1.09-1.81)
Male Reference Reference Reference
Cognitive impairment
CPSd 2+ 1.45 (1.13-1.87) 1.71 (1.12-2.62) 1.39 (1.04-1.85)
0-1 Reference Reference Reference
Gastrointestinal symptoms
Moderate-Severe 1.27 (1.03-1.55) 1.37 (1.06-1.76) N/Se
Minimal Reference Reference
# Co-morbidities
5+ N/Se 1.79 (1.24-2.59) N/Se
3-4 1.17 (0.90-1.51)
0-2 Reference
Supportive family
No strong family support N/Se N/Se 1.99 (1.20-3.30)
Strong family support Reference
Goodness of fit
C statistic (ROC curve) 0.77 (0.75-0.77)f 0.75 (0.74-0.76)f 0.76 (0.75-0.76)f
Hosmer & Lemeshow -χ2 5.27(1.5-14.1)f 7.89 (2.2-16.9)f 9.25 (3.0-16.9)f
-p 0.73 (0.08-0.99)f 0.49 (0.03-0.98)f 0.37 (0.03-0.93)f
-df 8 (8-8)f 8 (8-8)f 8 (8-8)f
a“High” life satisfaction indicates that the patient has all 5 of the following conditions present: a sense of completion, a sense of progress towards completion,
acceptance of the situation, inner strengths that can be encouraged/nurtured AND a positive outlook. “Low” life satisfaction” indicates that one or more of the
5 conditions are absent in the patient.
bCHESS = Changes in Health and End-Stage Disease Signs and Symptoms.
c“Sleep disorders” is a composite (summative) measure based on two items: too little sleep (5 severity levels ranging from 0 to 4) and too much sleep
(5 severity levels ranging from 0 to 4). “Severe” sleep disorders represent scores of 4+, “moderate” are scores of 2 or 3, and “minimal” are scores of 0 or 1.
dCPS = Cognitive Performance Scale.
eN/S = Not significant at alpha = 0.05 level.
fMean (Minimum-Maximum).
gAssumes a CHESS cutoff of 3+ versus <3 (to improve discriminatory power in this smaller sample focused on patients with prognosis < 6 months).
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depressive symptoms are not inevitable or integral to the
dying process [3,22]. While prevalence rates in palliative
patients are typically higher than the 2-5% found in the
general population [61], a recent review of depression in
cancer patients [8] cited lower rates similar to those
reported using the DRS in home care [62]. Also, few
studies have examined depression in palliative patients
treated at home, as we have done. One study reported a
depression rate of 13% in home care patients compared
to 33% for those treated in the hospital [32], but more
research is needed to better understand mental health
outcomes in home care settings.
Regarding the risk factors associated with depressive
symptoms, complete case and multiple imputation
analyses agreed on the selection of six factors: life
satisfaction, mortality (measured by CHESS or prognosis),
sleep disorders, pain, caregiver distress and gender.
The factors other than gender and mortality are
amenable to clinical intervention, thus we focus on these.
Life satisfaction was the risk factor with the strongest
association and, in this study, is a multidimensional
construct that includes prognostic acceptance, sense of
completion of personal goals/responsibilities, possession
of inner strengths, and possession of a positive outlook . It
is not surprising that the last two constructs, positive
outlook and inner strength, are associated with fewer
depressive symptoms. There is also evidence that the
other constructs are linked to depression. A study of 381
palliative cancer patients found that those who did not
accept their prognosis were more likely to have a diagnosis
of depression or anxiety disorder [29,63]. Breitbart [64]
sees acceptance of death as critical to many outcomes in
palliative patients, and as a result, he recommends that
this be a key goal of palliative care programs. Achieving a
sense of completion of life goals/responsibilities was iden-
tified as among the most important attributes of preparing
for end-of-life by patients, families, caregivers and health
care providers [65]. Some psychotherapeutic interventions
have shown promise in helping patients achieve a sense of
completion, including the Outlook intervention [66] and
dignity therapy [67]. Studies suggest that treatment
control may be a key factor in maintaining continued
optimism [68], suggesting that clinicians should emphasize
the positive aspects of treatments.
Physical symptoms such as sleep disorders, pain and
gastrointestinal disorders (identified in the multiple
imputation analyses) were also risk factors associated
with depressive symptoms in our study. Other research
confirms the linkage of these symptoms with depression
[2,5,12,20,21,69,70]. Further evidence of the association
between sleep disturbance and depression comes from
the clustering the former shows with depression [71],
and the widespread recognition of it as a symptom of
depression, leading to its inclusion in depression scales
like the Beck Depression Inventory II (tiredness/fatigue)
[72] and the Hamilton Depression Scale (insomnia) [73].
The cross-sectional nature of our study does not allow for
the determination of directionality, therefore, physical
symptoms may be the reason patients become depressed,
or depressed patients may focus more on their physical
symptoms. Other studies confirm this directional
uncertainty, particularly for sleep and gastrointestinal
disorders [4,5,74]. However, physical symptoms are also
intrinsic burdens normally treated to alleviate suffering in
palliative patients, regardless of their potential impact on
depression. The challenge is choosing medications to treat
physical symptoms with careful regard to the patient’s
comorbid conditions and the goals of the palliative
care program [75]. For example, a review of existing
medications is one of the first things done in treating
cognitive impairment, a symptom that is like sleep,
pain and gastrointestinal disorders in that it is often
present in palliative patients [71] and among the risk
factors for depressive symptoms [75,76].
Caregiver distress was a risk factor in our study. Other
studies using the DRS as a measure of depression have
found the same result [77,78]. The broader research on
depression and dementia indicates that patient depression
is one of the main causes of caregiver stress [79]. Some
studies have shown that behavioral interventions that
target the patient and include caregiver participation
can reduce depression in both groups [35]. Other studies
show that the provision of support to caregivers to improve
their coping strategies, with or without interventions for
the patient, positively influenced the quality of life of
dementia patients [80]. Higher odds of distress have
also been observed in caregivers that provide more
informal support [81], which is the case in our sample too,
and suggests that providing instrumental support to
caregivers and integrating informal and formal services
may reduce caregiver distress.
Cognitive impairment was associated with depressive
symptoms in the multiple imputation but not complete case
analyses. Multiple imputation, by correcting for increased
chance variation in complete cases, should generate
more unbiased, and thus reliable, results [54]. There
is also considerable evidence from other studies that
cognitive impairment and depression are syndromes that
co-exist, particularly in older adults and/or terminally-ill
[9,35,45,71,75,82]. The direction of the association between
the two is what remains unclear, because both have
overlapping symptoms, reciprocal effects and shared
etiologies [35,79,83]. This nevertheless suggests that
treating cognitive impairment may reduce depression.
Non-pharmacologic methods aimed at alleviating pre-
cipitating factors are recommended as the first form
of intervention to treat cognitive impairment, because
they have little to no downside and show high rates
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of reversibility in some groups (e.g., 50% reversibility in
patients with advanced cancer) [74-76]. Precipitating factors
include dehydration, poor nutrition, inadequate pain con-
trol, positioning that causes pressure ulcers or thrombosis,
poor lighting, sleep disruption, high noise levels, absence of
orienting influences, and lack of family involvement in
patient care [76]. Pharmacologic interventions are also
routinely used, even though no antipsychotic drugs
have yet been approved by the US Food and Drug
Administration for treatment of cognitive impairment [74].
Finally, we note that prognostic awareness was not a
risk factor for depressive symptoms in the multivariate
model, despite its strong bi-variate association with the
DRS, and its linkages with depression in other studies
[26]. Life satisfaction was found to mediate the main
effect of prognostic awareness on the DRS. However,
there may be an indirect impact of prognostic awareness
on the DRS through its relationship with life satisfaction.
This relationship in part reflects the dependency of
prognostic acceptance (a component of life satisfaction)
on awareness, since people need to be aware of something
in order to accept it. However, the relationship may be
more complex and involve other factors (e.g., spirituality,
existential distress). More research is needed, perhaps
using path analysis, to better understand the complex
relationship between depression, prognostic awareness,
and acceptance and what influence each of these has on
mental health.
We acknowledge several limitations that influence the
interpretation of the study results. The cross-sectional
design is one of this study’s primary limitations as it does
not allow us to determine causality. Future studies should
use longitudinal data where possible. The independent
variables included in the analysis were also restricted to
those available from the interRAI PC. While most of the
potential risk factors identified in the literature were
captured in the assessment, some were unavailable, includ-
ing: financial concerns, spirituality and existential distress
(available but low response), and history of patient/family
depression [21]. This limitation also affected our ability to
fully explore the significance of prognostic awareness,
because this interRAI PC item pertained to a smaller
sample of patients. The resulting smaller sample may have
failed to capture the full variation in some variables and
may be subject to ascertainment bias (e.g., the factors
shaping prognostic awareness and its association with
the DRS may be different in patients having a shorter
prognosis). We also did not employ diagnostic interviews
(the “gold standard”) to identify depression. However, the
DRS has been shown to be reliable for use as a clinical
screen for depression, having been validated against
psychiatric diagnoses [36] and validated in the palliative
care population. We did not have information on medica-
tion use, thus the prevalence rate of depressive symptoms
observed in our study may underestimate the true
underlying rate due to patients’ use of antidepressants.
Despite these limitations, this study has a number of
strengths. One strength is the large sample size, which
enhances the reliability of our results and overcomes the
high non-participation rates in other studies [6]. We also
included a large number of covariates, which helps to
identify the most significant risk factors for depressive
symptoms, and can assist clinicians and care providers in
understanding how best to screen for and treat depression
in this population.
Conclusions
This paper examined the covariates associated with depres-
sive symptoms in palliative home care patients. While more
research is needed to confirm our findings and determine
causality, the results nevertheless highlight potential risk
factors, most of which are amenable to clinical intervention
and emphasized in palliative care programs. For example,
pain, sleep and gastrointestinal disorders were significant
risk factors in our study, and most palliative care programs
aim to alleviate these and physical suffering generally. The
challenge is treating physical symptoms concomitantly with
the comorbidities often seen in palliative patients, such as
cognitive impairment (also a risk factor in our study) that is
caused or worsened by medications used to treat physical
symptoms. Another key implication of our study’s results is
providing coping-strategy-instrumental-based support to
caregivers. Though often overlooked in traditional medical
systems, caregiver needs fit within the palliative care
philosophy of treating the patient as part of a larger social
system. Life satisfaction may be the most challenging to
address, likely requiring interventions that target key
constructs such as emphasizing the positive aspects of
treatments to encourage optimism, using psychotherapeutic
interventions to help patients achieve a sense of comple-
tion, and assisting patients with acceptance of their death.
Since acceptance is individualistic, consideration must be
given to individual preferences for ambiguity about
the future and details on illness [68]. Finally, gender and
mortality were risk factors in our study and others
[2,9,25,84], but they are not modifiable. Their relevance lies
in ensuring that resources are available to more frequently
screen females and patients closer to death.
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